Management of Heart Transplant Recipients: Reference for Primary Care Physicians

References

• . Stehlik J, Edwards LB, Kucheryavaya AY, . The registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult heart transplant report—2011. J Heart Lung Transplant. 2011;30(10):1078–1094
   PubMedGoogle Scholar
• . Kobashigawa JA. Postoperative management following heart transplantation. Transplant Proc. 1999;31(5):2038–2046
   PubMedGoogle Scholar
• . Stark RP, McGinn AL, Wilson RF. Chest pain in cardiac transplant recipients. Evidence of sensory reinnervation after cardiac transplantation. N Engl J Med. 1991;324(25):1791–1794
   PubMedGoogle Scholar
• . Kobashigawa JA, Leaf DA, Lee N, . A controlled trial of exercise rehabilitation after heart transplantation. N Engl J Med. 1999;340(4):272–277
   PubMedGoogle Scholar
• . Kobashigawa JA, Miller LW, Russell SD, ; Study Investigators. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. Am J Transplant. 2006;6(6):1377–1386
   PubMed Web of Science ®Google Scholar
• . Kobashigawa JA, Patel J, Furukawa H, . Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients. J Heart Lung Transplant. 2006; 25(4):434–439
   PubMed Web of Science ®Google Scholar
• . Kobashigawa J, Miller L, Renlund D, . A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. Transplantation. 1998;66(4):507–515
   PubMed Web of Science ®Google Scholar
• . Mancini D, Pinney S, Burkhoff D, . Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation. 2003;108(1):48–53
   PubMed Web of Science ®Google Scholar
• . Eisen HJ, Tuzcu EM, Dorent R, ; RAD B253 Study Group. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med. 2003;349(9):847–858
   PubMed Web of Science ®Google Scholar
• . Constanzo MR, Dipchand A, Starling R, ; International Society of Heart and Lung Transplantation Guidelines. The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29(8):914–956
   PubMedGoogle Scholar
• . O'Connell JB, Bourge RC, Costanzo—Nordin MR, . Cardiac transplantation: recipients selection, donor procurement, and medical follow-up. A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1992;86(3):1061–1079
   PubMed Web of Science ®Google Scholar
• . Zuckermann AO, Aliabidi AZ. Calcineurin-inhibitor minimization protocols in heart transplantation. Transpl Int. 2009;22(1):78–89
   PubMedGoogle Scholar
• . Kobashigawa JA, Renlund DG, Gerosa G, ; ERL2401 Heart Study Investigators. Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter study. J Heart Lung Transplant. 2006;25(8):935–941
   PubMedGoogle Scholar
• . Kobashigawa JA, Stevenson LW, Brownfield ED, . Initial success of steroid weaning late after heart transplantation. J Heart Lung Transplant. 1992;11(2 pt 2):428–430
   PubMedGoogle Scholar
• . Kobashigawa JA, Stevenson LW, Brownfield ED, . Corticosteroid weaning late after heart transplantation: relation to HLA-DR mismatching and long term metabolic benefits. J Heart Lung Transplant. 1995;14(5):963–967
   PubMedGoogle Scholar
• . Patel JK, Kobashigawa JA. Everolimus for cardiac allograft v asculopathy—every patient, at any time? Transplantation. 2011;92(2):127–128
   PubMedGoogle Scholar
• . Stewart S, Winters GL, Fishbein MC, . Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24(11):1710–1720
   PubMed Web of Science ®Google Scholar
• . Kobashigawa J, Crespo—Leiro MG, Ensminger SM, ; Consensus Conference Participants. Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant. 2011;30(3):252–269
   PubMed Web of Science ®Google Scholar
• . Kobashigawa JA, Stevenson LW, Moriguchi JD, . Is intravenous glucocorticoid therapy better than an oral regimen for asymptomatic cardiac rejection? A randomized trial. J Am Coll Cardiol. 1993;21(5):1142–1114
   PubMedGoogle Scholar
• . Wu GW, Kobashigawa JA, Fishbein MC, . Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant. 2009;28(5):417–422
   PubMed Web of Science ®Google Scholar
• . Kosek JC, Hurley EJ, Lower RR. Histopathology of orthotopic canine cardiac homografts. Lab Invest. 1968;19(1):97–112
   PubMedGoogle Scholar
• . Kosek JC, Hurley EJ, Sewell DH, Lower RR. Histopathology of orthotopic canine cardiac homografts and its clinical correlation. Transplant Proc. 1969;1(1):311–315
   PubMedGoogle Scholar
• . Thomson JG. Production of severe atheroma in a transplanted human heart. Lancet. 1969;2(7630):1088–1092
   PubMedGoogle Scholar
• . Bieber CP, Stinson EB, Shumway NE, Payne R, Kosek J. Cardiac transplantation in man. VII. Cardiac allograft pathology. Circulation. 1970;41(5):753–772
   PubMedGoogle Scholar
• . Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant. 1992;11(3 pt 2):S38–S44
   PubMed Web of Science ®Google Scholar
• . Day JD, Rayburn BK, Gaudin PB, . Cardiac allograft vasculopathy: the central pathogenetic role of ischemia-induced endothelial cell injury. J Heart Lung Transplant. 1995;14(6 pt 2):S142–S149
   PubMedGoogle Scholar
• . Johnson MR. Transplant coronary disease: nonimmunologic risk factors. J Heart Lung Transplant. 1992;11(3 pt 2):S124–S132
   PubMedGoogle Scholar
• . Winters G, Kendall TJ, Radio SJ, . Posttransplant obesity and hyperlipidemia: major predictors of severity of coronary arteriopathy in failed human heart allografts. J Heart Lung Transplant. 1990;9(4): 364–371
   Google Scholar
• . Gibbons GH. The pathogenesis of graft vascular disease: implications of vascular remodeling. J Heart Lung Transplant. 1995;14(6 pt 2): S149–S158
   PubMedGoogle Scholar
• . Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol. 1988;12(2):334–340
   PubMedGoogle Scholar
• . Mehra MR, Crespo—Leiro MG, Dipchand A, . International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy—2010. J Heart Lung Transplant. 2010;29(7):717–727
   PubMed Web of Science ®Google Scholar
• . Kobashigawa JA, Tobis JM, Starling RC, . Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol. 2005;45(9):1532–1537
   PubMed Web of Science ®Google Scholar
• . Kobashigawa JA, Katznelson S, Laks H, . Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 1995; 333(10):621–627
   PubMed Web of Science ®Google Scholar
• . Cutts JL, Scallen TJ, Watson J, Bankhurst AD. Role of mevalonic acid in the regulation of natural killer cell cytotoxicity. J Cell Physiol. 1989;139(3);550–557
   PubMedGoogle Scholar
• . Fang JC, Kinlay S, Beltrame J, . Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet. 2002;359(9312):1108–1113
   PubMed Web of Science ®Google Scholar
• . Miller LW, Schlant RC, Kobashigawa J, Kubo S, Renlund DG. 24th Bethesda Conference: Cardiac Transplantation. Task Force 5: Complications. J Am Coll Cardiol. 1993;22(1):41–54
   PubMedGoogle Scholar
• . Armitage JM, Kormos RL, Stuart RS, . Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant. 1991;10(6):877–887
   PubMed Web of Science ®Google Scholar
• . Kobashigawa JA. Pathophysiology of the transplanted heart and its influence on exercise tolerance. In: Balady GL, Pina IL, eds. Exercise and Heart Failure. Armonk, NY: Futura Publishing Company, Inc.; 1997
   Google Scholar